Cargando…

Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest solid cancers with dismal prognosis. Several mechanisms that are mainly responsible for aggressiveness and therapy resistance of PDAC cells include epithelial to mesenchymal transition (EMT), stemness and Mitogen Activated Protein Kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huai, Yanyan, Zhang, Yushan, Xiong, Xunhao, Das, Shamik, Bhattacharya, Resham, Mukherjee, Priyabrata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shared Science Publishers OG 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702449/ https://www.ncbi.nlm.nih.gov/pubmed/31440741 http://dx.doi.org/10.15698/cst2019.08.195

Ejemplares similares

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells
por: Zhang, Yushan, et al.
Publicado: (2020)

Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells
por: Gannon, Christopher J, et al.
Publicado: (2008)

Experimental conditions influence the formation and composition of the corona around gold nanoparticles
por: Hossen, Md. Nazir, et al.
Publicado: (2021)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics
por: Kudgus, Rachel A., et al.
Publicado: (2013)

Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth
por: Hossen, Md. Nazir, et al.
Publicado: (2022)

The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress
por: Bhattacharya, Udayan, et al.
Publicado: (2022)

Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro
por: Elechalawar, Chandra Kumar, et al.
Publicado: (2020)

Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19
por: Zhang, Yushan, et al.
Publicado: (2021)

Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
por: Mukherjee, Priyabrata, et al.
Publicado: (2007)

When the chains do not break: the role of USP10 in physiology and pathology
por: Bhattacharya, Udayan, et al.
Publicado: (2020)

Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis
por: Mukherjee, Priyabrata, et al.
Publicado: (2013)

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Polymer coated gold nanoshells for combinational photochemotherapy of pancreatic cancer with gemcitabine
por: Emamzadeh, Mina, et al.
Publicado: (2021)

Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
por: Li, Hua, et al.
Publicado: (2017)

Inorganic phosphate nanorods are a novel fluorescent label in cell biology
por: Patra, Chitta Ranjan, et al.
Publicado: (2006)

Targeting the TGFβ pathway in uterine carcinosarcoma
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2020)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
por: Khan, Jameel Ahmad, et al.
Publicado: (2011)

Harmine suppresses the proliferation of pancreatic cancer cells and sensitizes pancreatic cancer to gemcitabine treatment
por: Wu, Lin-Wen, et al.
Publicado: (2019)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
por: Blaauboer, Amber, et al.
Publicado: (2020)

Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
por: García-Garrido, Eduardo, et al.
Publicado: (2021)

Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine
por: Yin, Tao, et al.
Publicado: (2016)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway
por: Zhou, Yunjiang, et al.
Publicado: (2019)

UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy
por: Lin, Lizhou, et al.
Publicado: (2018)

Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2
por: Dey, Anindya, et al.
Publicado: (2020)

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
por: Chen, Ru, et al.
Publicado: (2017)

Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway
por: Zhang, Tianli, et al.
Publicado: (2022)

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles
por: Arvizo, Rochelle R., et al.
Publicado: (2011)

DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine
por: Liu, Fang, et al.
Publicado: (2014)

Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
por: DUONG, HONG-QUAN, et al.
Publicado: (2013)

CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine
por: Xu, Peng, et al.
Publicado: (2016)

Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
por: Panebianco, Concetta, et al.
Publicado: (2021)

Pancreatic cancer cells spectral library by DIA-MS and the phenotype analysis of gemcitabine sensitivity
por: Kong, Ran, et al.
Publicado: (2022)

Small Non-Coding-RNA in Gynecological Malignancies
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2021)

Pancreatic Cancer Chemoresistance to Gemcitabine
por: Amrutkar, Manoj, et al.
Publicado: (2017)

Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis
por: Ouyang, Guoqing, et al.
Publicado: (2016)

Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles
por: Arvizo, Rochelle R., et al.
Publicado: (2012)

Gemcitabine Conjugated Chitosan and Double Antibodies (Abc-GC-Gemcitabine Nanoparticles) Enhanced Cytoplasmic Uptake of Gemcitabine and Inhibit Proliferation and Metastasis In Human SW1990 Pancreatic Cancer Cells
por: Xiao, Jun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q99m246gp8e3hnj820cq96ikip